SCHEMBL463262

SCHEMBL463262

Cn1ncc2ccccc21.O=[C]O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMO O15229 1/20 0.46
CYP1A2 P05177 1/20 0.44
ELANE P08246 1/20 0.41
NPC1 O15118 1/20 0.40
ALDH1A1 P00352 1/20 0.40
MAPT P10636 1/20 0.40
HPGD P15428 1/20 0.40
ALOX12 P18054 1/20 0.40
RAB9A P51151 1/20 0.40
TRPA1 O75762 1/20 0.40
RECQL P46063 2/20 0.40
POLB P06746 1/20 0.39
HSD17B10 Q99714 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
NOTUM Q6P988 1/20 0.39
ASAH1 Q13510 1/20 0.38
ERCC1 P07992 1/20 0.38
ERCC4 Q92889 1/20 0.38
CDK8 P49336 1/20 0.38
SLC22A12 Q96S37 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29487677 0.88 CYP1A2 (0.47) KMOCYP1A2ELANENPC1ALDH1A1
SCHEMBL47226 0.88 CYP1A2 (0.47) KMOCYP1A2ELANENPC1ALDH1A1
Fluoride SCHEMBL31655450 0.86 CYP1A2 (0.46) KMOCYP1A2ELANENPC1ALDH1A1
Formic Acid SCHEMBL27515529 0.84 KMO (0.45) KMOCYP1A2ELANENPC1ALDH1A1
Trifluoroacetic Acid SCHEMBL31197687 0.80 KMO (0.49) KMOELANENPC1ALDH1A1MAPT
SCHEMBL29487791 0.77 TRPA1 (0.42) KMOCYP1A2NPC1ALDH1A1MAPT
SCHEMBL28449338 0.75 RECQL (0.41) KMOCYP1A2TRPA1RECQLCDK8
SCHEMBL31097138 0.75 RECQL (0.43) KMOCYP1A2ELANEALDH1A1MAPT
Quinoline SCHEMBL27698764 0.74 ALDH1A1 (0.57) KMOCYP1A2NPC1ALDH1A1RAB9A
SCHEMBL29487819 0.73 TRPA1 (0.39) KMOCYP1A2NPC1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2613781-A1 INDAZOLE DERIVATIVES FOR USE IN THE TREATMENT OF INFLUENZA VIRUS INFECTION GlaxoSmithKline Intellectual Property Development Limited (GB) 2013-07-17 EP disclosed
WO-2012032065-A1 INDAZOLE DERIVATIVES FOR USE IN THE TREATMENT OF INFLUENZA VIRUS INFECTION GLAXO GROUP LIMITED (GB) 2012-03-15 WO disclosed